SLC2A1 and Alzheimer disease: We identified five hub genes (JUN, SLC2A1, TFRC, ALB, and NFE2L2) that are closely associated with ferroptosis in AD and can differentiate AD patients from controls, and are thus potential ferroptosis-related biomarkers for disease diagnosis and therapeutic monitoring.